Translation and Adaptation of the STOPP/START Criteria Version 3 for Potentially Inappropriate Prescribing in Older People to European Portuguese: A Study Protocol

Daniela A. Rodrigues; Fátima Roque; Maria Teresa Herdeiro; Luís Monteiro

doi:10.20344/amp.21941

Autores

Daniela A. Rodrigues Biotechnology Research. Innovation and Design for Health Products (BRIDGES). Research Laboratory on Epidemiology and Population Health. Instituito Politécnico da Guarda. Guarda; Health Sciences Research Centre (CICS). Universidade da Beira Interior. Covilhã; Universidad de Salamanca. Salamanca.
Fátima Roque Biotechnology Research. Innovation and Design for Health Products (BRIDGES). Research Laboratory on Epidemiology and Population Health. Instituito Politécnico da Guarda. Guarda; Health Sciences Research Centre (CICS). Universidade da Beira Interior. Covilhã.
Maria Teresa Herdeiro Department of Medical Sciences. Institute of Biomedicine (iBiMED). Universidade de Aveiro. Aveiro.
Luís Monteiro Department of Medical Sciences. Institute of Biomedicine (iBiMED). Universidade de Aveiro. Aveiro; Centre for Health Technology and Services Research (CINTESIS). Faculty of Medicine. Universidade do Porto. Porto; Unidade de Saúde Familiar Esgueira Mais. Unidade Local de Saúde da Região de Aveiro. Aveiro.

DOI:

https://doi.org/10.20344/amp.21941

Palavras-chave:

Idoso, Lista de Medicamentos Potencialmente Inapropriados, Padrões de Prática Médicos, Portugal, Prescrição Inapropriada, Prescrição de Medicamentos

Resumo

Introdução: À medida que a população mundial está a envelhecer, a gestão do uso de medicamentos em idosos torna-se cada vez mais complexa devido à polimedicação e aos riscos associados a eventos adversos relacionados com os medicamentos. Para melhorar a segurança e o uso de medicamentos nesta população foram desenvolvidos critérios como os Screening Tool of Older Persons’ Prescriptions (STOPP) e Screening Tool to Alert doctors to Right Treatment (START). A disponibilização de critérios atualizados revela-se crucial para apoiar os profissionais de saúde portugueses. Este estudo tem como objetivo traduzir e validar a versão 3 dos critérios STOPP-START para a língua portuguesa, disponibilizando uma ferramenta útil e devidamente atualizada para os profissionais de saúde.
Métodos e Análise: Este estudo será realizado através de quatro etapas: I) tradução para a língua portuguesa da versão 3 dos critérios STOPP/START; II) recolha de dados sociodemográficos, clínicos e sobre medicamentos; III) estudo de confiabilidade intra-avaliador; e IV) estudo de concordância interavaliador. Este estudo obteve parecer favorável da Comissão de Ética da Administração Regional de Saúde do Centro (ARSC) de Portugal. A disponibilização dos critérios traduzidos permitirá a integração dos critérios STOPP/START versão 3 na prática clínica em Portugal, promovendo uma melhoria na segurança e no uso de medicamentos. Espera-se que esta integração leve a uma melhor gestão da polimedicação e a uma redução nos eventos adversos relacionados com os medicamentos, melhorando os resultados para os doentes e apoiando práticas de prescrição baseadas em evidência.

Downloads

Não há dados estatísticos.

Referências

United Nations. World population prospects 2022. 2022. [cited 2024 Apr 15]. Available from: https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/wpp2022_summary_of_results.pdf.

Rudnicka E, Napierała P, Podfigurna A, Męczekalski B, Smolarczyk R, Grymowicz M. The World Health Organization (WHO) approach to healthy ageing. Maturitas. 2020;139:6-11.

Pérez-Jover V, Mira JJ, Carratala-Munuera C, Gil-Guillen VF, Basora J, López-Pineda A, et al. Inappropriate use of medication by elderly, polymedicated, or multipathological patients with chronic diseases. Int J Environ Res Public Health. 2018;15:310.

Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:230.

Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol. 2015;71:1415-27.

Motter FR, Fritzen JS, Hilmer SN, Paniz ÉV, Paniz VM. Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria. Eur J Clin Pharmacol. 2018;74:679-700.

Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825-32.

Fick D, Semla T, Beizer J, Brandt N, Dombrowski R, DuBeau CE, et al. American Geriatrics Society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616-31.

Samuel MJ. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63:2227-46.

Fick DM, Semla TP, Steinman M, Beizer J, Brandt N, Dombrowski R, et al. American Geriatrics Society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674-94.

American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71:2052-81.

Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (screening tool of older person’s prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46:72-83.

O’mahony D, O’sullivan D, Byrne S, O’connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age Ageing. 2015;44:213-8.

O’Mahony D, Cherubini A, Guiteras AR, Denkinger M, Beuscart JB, Onder G, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med. 2023;14:625-32.

Aguiar JP, Gama Marques J, Alves da Costa F. Utility and limitations of a screening tool of older person’s prescription among psychiatric elder patients: a comprehensive review. Aging Health Res. 2021;1:100031.

Tian F, Chen Z, Zeng Y, Feng Q, Chen X. Prevalence of use of potentially inappropriate medications among older adults worldwide: a systematic review and meta-analysis. JAMA Netw Open. 2023;6:e2326910.

De Oliveira Martins S, Soares MA, Foppe Van Mil JW, Cabrita J. Inappropriate drug use by Portuguese elderly outpatients - effect of the beers criteria update. Pharmacy World and Science. 2006;28:296-301.

Eiras A, Teixeira MA, González-Montalvo JI, Castell MV, Queipo R, Otero Á. Consumption of drugs in over 65 in Porto (Portugal) and risk of potentially inappropriate medication prescribing. Aten Primaria. 2016;48:110-20.

Simões PA, Santiago LM, Maurício K, Simões JA. Prevalence of potentially inappropriate medication in the older adult population within primary care in Portugal: a nationwide cross-sectional study. Patient Prefer Adherence. 2019;13:1569-76.

Monteiro C, Canário C, Ribeiro MÂ, Duarte AP, Alves G. Medication evaluation in Portuguese elderly patients according to beers, stopp/start criteria and EU(7)-PIM list – an exploratory study. Patient Prefer Adherence. 2020;14:795-802.

da Costa FA, Periquito C, Carneiro MC, Oliveira P, Fernandes AI, Cavaco-Silva P. Potentially inappropriate medications in a sample of Portuguese nursing home residents: does the choice of screening tools matter? Int J Clin Pharm. 2016;38:1103-11.

Peixoto S, Almeida A, Caramelo A, Mendes L. Application of the 2015 beers criteria operationalized for portugal in institutionalized elderly: a crosssectional study. Acta Med Port. 2020;33:741-8.

Aguiar JP, Costa LH, da Costa FA, Leufkens HG, Martins AP. Identification of potentially inappropriate medications with risk of major adverse cardiac and cerebrovascular events among elderly patients in ambulatory setting and long-term care facilities. Clin Interv Aging. 2019;14:535-47.

AL-Musawe L, Torre C, Guerreiro JP, Rodrigues AT, Raposo JF, Mota-Filipe H, et al. Polypharmacy, potentially serious clinically relevant drug-drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life. Pharmacol Res Perspect. 2020;8:e00621.

Perpétuo C, Plácido AI, Rodrigues D, Aperta J, Piñeiro-Lamas M, Figueiras A, et al. Prescription of potentially inappropriate medication in older inpatients of an internal medicine ward: concordance and overlap among the EU(7)-PIM list and beers and STOPP Criteria. Front Pharmacol. 2021;12:676020.

Candeias C, Gama J, Rodrigues M, Falcão A, Alves G. Potentially inappropriate medications and potential prescribing omissions in elderly patients receiving post-acute and long-term care: application of screening tool of older people’s prescriptions/screening tool to alert to right treatment criteria. Front Pharmacol. 2021;12:747523.

Plácido AI, Aguiar A, Piñeiro-Lamas M, Varallo F, Figueiras A, Herdeiro MT, et al. Assessment of potentially inappropriate medications using the EU (7)-PIM List, in a sample of portuguese older adults’ residents in nursing homes. Risk Manag Healthc Policy. 2022;15:1343-52.

Monteiro L, Monteiro-Soares M, Matos C, Ribeiro-Vaz I, Teixeira A, Martins C. inappropriate prescriptions in older people—translation and adaptation to portuguese of the STOPP/START Screening Tool. Int J Environ Res Public Health. 2022;19:6896.

Dalleur O, Pharm M, Lang PO, Boland B. La nouvelle version des critères STOPP/START adaptée en français. Pharmactuel. 2016;49:61-4.

Delgado-Silveira E, Molina Mendoza MD, Montero-Errasquín B, García MM, Rodríguez Espeso EA, Vélez-Díaz-Pallarés M, et al. Spanish version of the STOPP/START 3 criteria: Advances in the detection of inappropriate prescribing medication in the older people. Rev Esp Geriatr Gerontol. 2023;58:101407.

Vermeulen Windsant-van den Tweel AM, Verduijn MM, Derijks HJJ, van Marum RJ. Detectie van ongeschikt medicatiegebruik bij ouderen; worden de STOPP-en START-criteria de nieuwe standaard? Ned Tijdschr Geneeskd. 2012;156:A5076.

Kojima T, Mizukami K, Tomita N, Arai H, Ohrui T, Eto M, et al. Screening tool for older persons’ appropriate prescriptions in japanese: report of the Japan Geriatrics Society Working Group on “guidelines for medical treatment and its safety in the elderly.” Geriatr Gerontol Int. 2016;16:983-1001.

Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8:94-104.

Streiner DL, Norman GR. Biases in responding. In: Health Measurement Scales. Oxford: Oxford University Press; 2009.

Shoukri MM. Measures of interobserver agreement and reliability. Boca Raton: CRC Press; 2010.

Kottner J, Audige L, Brorson S, Donner A, Gajewski BJ, Hróbjartsson A, et al. Guidelines for reporting reliability and agreement studies (GRRAS) were proposed. Int J Nurs Stud. 2011;48:661-71.

Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-74.

Laatikainen O, Sneck S, Turpeinen M. Medication-related adverse events in health care—what have we learned? A narrative overview of the current knowledge. Eur J Clin Pharmacol. 2022;78:159-70.

Falemban AH. Medication-related problems and their intervention in the geriatric population: a review of the literature. Cureus. 2023:e44594.

Direção-Geral da Saúde. Norma N.o 018/2016 reconciliação da medicação. 2016. [cited 2024 Aug 07]. Available from: https://normas.dgs.min-saude.pt/wp-content/uploads/2019/10/reconciliacao-da-medicacao.pdf.